A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in efforts to vaccinate certain parts of the world, offering an inexpensive, easy-to-store and effective alternative to RNA vaccines.
A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in efforts to vaccinate certain parts of the world, offering an inexpensive, easy-to-store and effective alternative to RNA vaccines.